PSBD:NYSEPalmer Square Capital BDC Inc. Analysis
Data as of 2026-06-14 - not real-time
$10.77
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Palmer Square Capital BDC trades around $10.77, just above its 20‑day SMA (≈$10.75) and 50‑day SMA (≈$10.70) but well below the 200‑day SMA (≈$11.67), signaling a short‑term neutral stance within a longer‑term downtrend. The RSI sits near 51 and the MACD has turned bearish, while volume has been slipping, suggesting limited upside momentum. On the fundamentals side, the forward P/E of roughly 7.6 is well under the industry average of 16.8, indicating an undervalued price, yet the dividend yield of ~14% is backed by a payout ratio near 400%, raising serious sustainability concerns. Recent board approval to increase and extend the share‑repurchase program signals management confidence, but the high dividend payout and a max drawdown of about 34% underscore the need for caution.
Overall, PSBD offers an attractive valuation and a low beta (≈0.54) that tempers market risk, but the combination of a bearish technical picture, decreasing liquidity, and an unsustainable dividend suggests a watchful‑wait approach rather than aggressive buying.
Overall, PSBD offers an attractive valuation and a low beta (≈0.54) that tempers market risk, but the combination of a bearish technical picture, decreasing liquidity, and an unsustainable dividend suggests a watchful‑wait approach rather than aggressive buying.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price hovering just above short‑term support (≈$10.5)
- Bearish MACD and decreasing volume
- High, likely unsustainable dividend yield
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Undervalued forward P/E (~7.6) versus industry
- Share‑repurchase program indicating management confidence
- Continued dividend sustainability concerns
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Low beta and moderate volatility reduce market risk
- Potential earnings upside reflected in positive forward EPS
- Value‑oriented pricing with room for price appreciation if dividend policy stabilizes
Key Metrics & Analysis
Financial Health
P/E Ratio7.7
Industry P/E16.8
Technical Analysis
TrendNeutral
RSI50.9
Support$10.50
Resistance$11.06
MA 20$10.75
MA 50$10.70
MA 200$11.67
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Target Price$11.00
Upside/Downside2.14%
GradeUndervalued
TypeValue
Dividend Yield13.93%
Risk Assessment
Beta0.54
Volatility20.45%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.